The Génie Talks

Notes on genomics, personalised healthcare and precision diagnostics from the team at Genique Lifesciences.

A single pink letter C above the sequence A T G A C G C A G from the phiX174 genome, labelled nanopore. By Abhishek Das · 26 Oct 2026

Nobody has ever read a letter

Not one sequencing platform reads a letter. Each measures something a letter causes, and works backwards from it: a photon, a shift in acidity, a current.

4 min read → 03h00 in large pink type, above the line: almost none of the 48 hours went on sequencing. By Abhishek Das · 19 Oct 2026

Photographs of a piece of glass

There is a way of reading DNA that works by photographing a piece of glass, several hundred times. The chemistry was ingenious. The idea under it was plain.

3 min read → The author list of the human genome paper, grouped under the Whitehead Institute, the Sanger Centre and Washington University, ending in et al. Cited as Nature 409, 2001. By Abhishek Das · 15 Sept 2026

What 1990 actually bought

In 1990, serious biologists argued that reading the human genome would be a waste of money. That part gets left out of the moonshot version.

4 min read → Three rows of identical dark grey shapes, one of them picked out in pink. By Abhishek Das · 7 Sept 2026

A billion copies of a question mark

In 1983 a chemist named Kary Mullis pulled over on Highway 128 with an idea worth stopping for. Copying DNA is a solved problem. What the copies mean is not.

6 min read → A wall of DNA letters from the phiX174 genome, fading towards the bottom of the frame. By Abhishek Das · 20 Aug 2026

What the 1977 paper actually says

His name was Frederick Sanger. He is sometimes called the father of genomics and almost nobody outside a lab has heard of him. He went home to his garden most evenings and disliked fuss so thoroughly that he turned down a knighthood, because he did not fancy being called Sir.

6 min read → Nine biomarkers in a row. EGFR, ALK, ROS1 and RET come before a line marked tissue exhausted; BRAF, KRAS G12C, MET exon 14, ERBB2 and NTRK fade out after it. By Abhishek Das · 1 Aug 2026

Four millimetres

What lung cancer testing actually runs out of in an Indian lab. Not awareness, not approved drugs, but tissue, spent one question at a time.

7 min read → The same findings drawn twice: a dense page of lines built for the machine, and four short bars built for the person, one of them pink. By Abhishek Das · 13 Jul 2026

The last mile of a genome

The sequencing is extraordinary and the interpretation is careful, and then it's poured into a report built for the machine that produced it, not the person reading it.

4 min read → Five equal blocks: the instrument in pink, then the test menu, the cash trough, accreditation and the people. The box is roughly a fifth of what decides whether in-house sequencing works. By Abhishek Das · 26 Jun 2026

The sequencer is the easy part

Why the person who sells you the box wants you to stop worrying about it. The instrument is maybe a fifth of what decides whether in-house sequencing works.

5 min read → Bar chart of litres of milk per lactation: 1,500 for the average Indian dairy cow, 2,300 for the global average, 10,000 for elite Holstein herds in the US and Israel. By Abhishek Das · 29 May 2026

Sequencing the herd: how next-generation genomics could reshape Indian dairy

India leads the world in milk volume and lags badly in yield per animal. Genomic selection can close that gap, but not before the reference-population, aggregation and bioinformatics work is done.

9 min read → Cancer stages I to IV on a line. A grey bar marks where cure is achievable, at the early stages; a pink bar marks where precision oncology is deployed, at the late ones. By Abhishek Das · 4 May 2026

Shifting the paradigm: moving precision oncology from late-stage lifeline to early-stage cure

Precision oncology works, mostly once disease is advanced and cure is often no longer the goal. The biological case for moving it upstream is strong; the infrastructure to carry it is not there yet.

5 min read → A bell curve with a pink line at its peak, labelled the median patient. By Abhishek Das · 30 Apr 2026

The molecular map: how genomic sequencing is rewriting the rules of medicine

Sequencing has gone from expensive scientific wonder to fundamental utility, dismantling the medicine of averages across oncology, pharmacology, reproductive health and rare disease.

4 min read → A grid of several hundred grey squares with a single one in pink. By Abhishek Das · 22 Apr 2026

The unfinished map: why whole genome is the new standard

The exome reads only the highlighted sentences. In the NICU, where hours decide a lifetime of outcomes, whole genome sequencing is fast becoming the first-line test rather than the upgrade.

4 min read → Two people on a scale of inherited risk, person B well above person A, captioned: the same routine, from a different starting line. By Srishti Sudan · 2 Dec 2025

Decoding diabetes: how genomics is shaping the future of screening and management

Diabetes has long been read as a lifestyle condition. Beneath diet and habit sits a deeper layer, your genes, and genomic screening can surface that risk years before symptoms do.

2 min read → Two lines of DNA letters labelled read and write, the second changing one C to a pink T, captioned: the decade we stopped only reading it, 2015–2025. By Srishti Sudan · 27 Oct 2025

The genomic decoding

A decade of progress has moved sequencing from a costly research tool to everyday clinical practice, reshaping oncology, rare disease, agriculture and how we understand life itself.

2 min read →

Set up an introduction meeting today.

Tell us about your lab and where you want to take it. We'll bring the right technology and team.

Email contact [at] genique.co Phone +91 124-426-3051
Office Unit-805, 8th Floor, Unitech Arcadia, South City-2, Sector 49, Gurugram, Haryana 122018

Phone: ten digits in India, or include the country code, such as +44.

By submitting this form you consent to Genique Lifesciences processing the details above to respond to your enquiry, and to their retention for 24 months from our last contact. You may withdraw consent at any time by emailing contact [at] genique.co. See our Privacy Policy.